SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.180-0.8%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: songw who wrote (785)1/16/1998 9:11:00 PM
From: OtherChap  Read Replies (1) of 3576
 
>there are a few too many fish swimming in the barrel to resist
>shooting them.

are the fish you refer to shorts or longs?

i was looking over this company, and there are only a total
of 10 million shares outstanding.. giving this company a
market cap of around 135 million as of today's close.

if this company has done their homework regarding patents,
and the "breakthrough" is really as impressive as people seem
to make it out to be, i wouldn't worry about long term
prospects or the fact that real drugs may be 5 years down the
line. a larger pharmaceutical company will simply buy them
out. even at twice the current stock price, that's just
a drop in the R&D bucket of any of the large drug companies.

i'll be watching 20/20 tonight, should be interesting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News